Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01

NCT07290894 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Vulva Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Lenvatinib Capsules

Sponsor

National Cancer Institute, Naples